{"id":"https://openalex.org/W7225823653","doi":"https://doi.org/10.1002/pds.70530","title":"Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population\u2010Based Matched Cohort Study","display_name":"Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population\u2010Based Matched Cohort Study","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225823653","doi":"https://doi.org/10.1002/pds.70530","pmid":"https://pubmed.ncbi.nlm.nih.gov/43010636"},"language":"en","primary_location":{"id":"doi:10.1002/pds.70530","doi":"https://doi.org/10.1002/pds.70530","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.70530","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70530","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70530","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008363804","display_name":"Osvaldo P. Almeida","orcid":"https://orcid.org/0000-0002-8689-6199","observed_orcids":["https://orcid.org/0000-0002-8689-6199"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I93396115","display_name":"The University of Notre Dame Australia","ror":"https://ror.org/02stey378","country_code":"AU","type":"education","lineage":["https://openalex.org/I93396115"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Osvaldo P. Almeida","raw_affiliation_strings":["Institute for Health Research University of Notre Dame  Fremantle Western Australia Australia","Medical School University of Western Australia  Perth Western Australia Australia"],"raw_orcid":"https://orcid.org/0000-0002-8689-6199","affiliations":[{"raw_affiliation_string":"Institute for Health Research University of Notre Dame  Fremantle Western Australia Australia","institution_ids":["https://openalex.org/I93396115"]},{"raw_affiliation_string":"Medical School University of Western Australia  Perth Western Australia Australia","institution_ids":["https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030462014","display_name":"Christopher Etherton\u2010Beer","orcid":"https://orcid.org/0000-0001-5148-0188","observed_orcids":["https://orcid.org/0000-0001-5148-0188"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christopher Etherton\u2010Beer","raw_affiliation_strings":["Medical School University of Western Australia  Perth Western Australia Australia"],"raw_orcid":"https://orcid.org/0000-0001-5148-0188","affiliations":[{"raw_affiliation_string":"Medical School University of Western Australia  Perth Western Australia Australia","institution_ids":["https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063416292","display_name":"Frank Mario Sanfilippo","orcid":"https://orcid.org/0000-0003-3639-0787","observed_orcids":["https://orcid.org/0000-0003-3639-0787"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Frank M. Sanfilippo","raw_affiliation_strings":["School of Population and Global Health University of Western Australia  Perth Western Australia Australia"],"raw_orcid":"https://orcid.org/0000-0003-3639-0787","affiliations":[{"raw_affiliation_string":"School of Population and Global Health University of Western Australia  Perth Western Australia Australia","institution_ids":["https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016849312","display_name":"David Brian Preen","orcid":"https://orcid.org/0000-0002-2982-2169","observed_orcids":["https://orcid.org/0000-0002-2982-2169"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David B. Preen","raw_affiliation_strings":["School of Population and Global Health University of Western Australia  Perth Western Australia Australia"],"raw_orcid":"https://orcid.org/0000-0002-2982-2169","affiliations":[{"raw_affiliation_string":"School of Population and Global Health University of Western Australia  Perth Western Australia Australia","institution_ids":["https://openalex.org/I177877127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041885062","display_name":"Amy Theresa Page","orcid":"https://orcid.org/0000-0002-2084-8469","observed_orcids":["https://orcid.org/0000-0002-2084-8469"]},"institutions":[{"id":"https://openalex.org/I196829312","display_name":"La Trobe University","ror":"https://ror.org/01rxfrp27","country_code":"AU","type":"education","lineage":["https://openalex.org/I196829312"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Amy Page","raw_affiliation_strings":["La Trobe Rural Health School La Trobe University  Bendigo Victoria Australia"],"raw_orcid":"https://orcid.org/0000-0002-2084-8469","affiliations":[{"raw_affiliation_string":"La Trobe Rural Health School La Trobe University  Bendigo Victoria Australia","institution_ids":["https://openalex.org/I196829312"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5008363804"],"corresponding_institution_ids":["https://openalex.org/I177877127","https://openalex.org/I93396115"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"11","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.7949000000953674,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.7949000000953674,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.14990000426769257,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9448999762535095},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.6668999791145325},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.586899995803833},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5058000087738037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4952999949455261},{"id":"https://openalex.org/C3019063607","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Charlson comorbidity index","level":3,"score":0.4575999975204468},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.44690001010894775},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44369998574256897},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38339999318122864},{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.3328000009059906},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.3273000121116638},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.3111000061035156},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.28459998965263367},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.26159998774528503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25920000672340393},{"id":"https://openalex.org/C3019323424","wikidata":"https://www.wikidata.org/wiki/Q18389","display_name":"New england","level":3,"score":0.25029999017715454}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D065186","descriptor_name":"Interrupted Time Series Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.70530","doi":"https://doi.org/10.1002/pds.70530","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.70530","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70530","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:43010636","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43010636","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/pds.70530","doi":"https://doi.org/10.1002/pds.70530","is_oa":true,"landing_page_url":"https://doi.org/10.1002/pds.70530","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70530","source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225823653.pdf","grobid_xml":"https://content.openalex.org/works/W7225823653.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W162134209","https://openalex.org/W1898025493","https://openalex.org/W1965598001","https://openalex.org/W2014196617","https://openalex.org/W2139214514","https://openalex.org/W2139560403","https://openalex.org/W2255146410","https://openalex.org/W2289341638","https://openalex.org/W2344080161","https://openalex.org/W3018284802","https://openalex.org/W3112729206","https://openalex.org/W3139368685","https://openalex.org/W3172791707","https://openalex.org/W3184238291","https://openalex.org/W3191531805","https://openalex.org/W3202631805","https://openalex.org/W4211205676","https://openalex.org/W4303986453","https://openalex.org/W4316928765","https://openalex.org/W4361000277","https://openalex.org/W4377967619","https://openalex.org/W4385568804","https://openalex.org/W4389054325","https://openalex.org/W4391811779","https://openalex.org/W4392762154","https://openalex.org/W4396954720","https://openalex.org/W4403398542","https://openalex.org/W4403796835","https://openalex.org/W4405078499","https://openalex.org/W4408630570","https://openalex.org/W4413294377","https://openalex.org/W4415017427","https://openalex.org/W7125611855"],"related_works":[],"abstract_inverted_index":{"PURPOSE:":[0],"Seizures":[1],"and":[2,4,71,73,97,108,143,182,232,237],"behavioural":[3],"psychiatric":[5,238],"features":[6],"may":[7],"prompt":[8],"antiseizure":[9],"medication":[10],"(ASM)":[11],"use":[12,259],"in":[13,57,128,221,228],"dementia.":[14],"We":[15,76],"examined":[16],"whether":[17],"increased":[18],"ASM":[19,79,124,214],"dispensing":[20,56,64,80,125,176,226,253],"precedes":[21],"or":[22],"follows":[23],"initiation":[24,93,133,148,186],"of":[25,164],"antidementia":[26,55,63,224],"treatment":[27],"to":[28,60,89,241],"inform":[29],"hypotheses":[30],"about":[31],"when":[32],"these":[33],"indications":[34,239],"emerge.":[35],"METHODS:":[36],"Using":[37],"the":[38,110,144,165],"Australian":[39],"Pharmaceutical":[40],"Benefits":[41],"Scheme":[42],"(PBS)":[43],"10%":[44],"sample,":[45],"we":[46],"matched":[47,116],"people":[48,222],"aged":[49],"\u2265":[50],"50":[51],"years":[52,87,91,131],"with":[53,223,243],"incident":[54],"2018-2021":[58],"1:1":[59],"controls":[61],"without":[62],"(2013-2024)":[65],"by":[66],"age,":[67],"sex,":[68],"index":[69],"year":[70,180],"diabetes":[72],"hypertension":[74],"treatment.":[75],"compared":[77],"annual":[78],"(ATC":[81],"N03,":[82],"excluding":[83],"gabapentinoids)":[84],"from":[85,179],"5":[86,130],"before":[88,132,231,250],"3":[90,168,188],"after":[92,147,185,234],"using":[94],"McNemar's":[95],"test":[96],"interrupted":[98],"time":[99],"series":[100],"analysis.":[101],"Sensitivity":[102],"analyses":[103],"re-matched":[104],"on":[105,196],"Rx-Risk":[106],"comorbidity":[107,197],"removed":[109],"survival":[111],"requirement.":[112],"RESULTS:":[113],"Among":[114],"4385":[115],"pairs":[117],"(59.8%":[118],"women;":[119],"mean":[120],"age":[121],"78.3":[122],"years),":[123],"was":[126,183,207,219],"higher":[127,184,220],"cases":[129],"(2.7%":[134],"vs.":[135,152],"1.8%;":[136],"ratio":[137,154,169,189,203],"1.53,":[138],"95%":[139,156,171,191],"CI":[140,157,172,192],"=":[141,158,173,193],"1.15-2.03)":[142],"difference":[145],"widened":[146],"(year":[149,167,187,201],"3:":[150],"9.1%":[151],"2.4%;":[153],"3.85,":[155],"3.13-4.75).":[159],"Valproate":[160,258],"accounted":[161],"for":[162],"most":[163,216],"excess":[166,206],"6.97,":[170],"4.80-10.12).":[174],"Levetiracetam":[175],"rose":[177],"gradually":[178],"-3":[181],"2.30,":[190],"1.51-3.50).":[194],"Matching":[195],"attenuated":[198],"pre-initiation":[199],"differences":[200],"-5":[202],"1.42).":[204],"The":[205],"greater":[208],"at":[209],"ages":[210],"50-79":[211],"years.":[212],"CONCLUSIONS:":[213],"dispensing,":[215],"noticeably":[217],"valproate,":[218],"medicine":[225],"than":[227],"controls,":[229],"modestly":[230],"markedly":[233],"initiation.":[235],"Behavioural":[236],"seem":[240],"predominate,":[242],"a":[244],"smaller":[245],"seizure-related":[246],"contribution":[247],"possibly":[248],"beginning":[249],"treatment,":[251],"although":[252],"data":[254],"cannot":[255],"confirm":[256],"indications.":[257],"warrants":[260],"review.":[261]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}